Synaptotagmin (Syt) belongs to a family of type-I membrane proteins and is a protein that consists of a short extracellular Nterminus, a single transmembrane domain, two C2 domains and a short C-terminus. Here, we cloned and characterized a mouse orthologue of human KIAA1427 protein as an atypical Syt (named Syt XIII). Subcellular fractionation and antibody-uptake experiments indicate that Syt XIII is indeed a type-I membrane protein, but, unlike other Syt isoforms, lacks an N-terminal extracellular domain. Syt XIII C2 domains show relatively little similarity to Syt I (less than 35 % identity at the amino acid level), and lack key amino acids responsible for Ca# + binding.
INTRODUCTION
Neurotransmitter release from nerve terminals in the brain is regulated by several families of Ca# + -binding proteins having tandem C2 domains (named the C2A domain and C2B domain ; reviewed in [1] ). These domains were originally found in the Ca# + -activated type of protein kinase C, and they are thought to function as a Ca# + -dependent phospholipid-binding site (reviewed in [2] ). Three proteins, synaptotagmin (Syt) I [1,3-5], rabphilin-3A (downstream target of rab3A) [6] and Doc2α [7] , have been identified on synaptic vesicles to date. Syt I, an integral membrane protein of synaptic vesicles, is essential for the fusion step between the synaptic vesicle and the presynaptic plasma membrane, probably functioning as a Ca# + sensor via the C2A domain [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . By contrast, the latter two proteins play a regulatory role in a step before the final fusion step of the synaptic vesicle with the presynaptic plasma membrane [19, 20] .
Syts now constitute a large protein family in both vertebrates and invertebrates (reviewed in [4, 5] ). All members show type-I membrane topology (N extracellular \C cytoplasmic orientation) and lack a signal-peptide sequence [21] . They consist of a short extracellular N-terminus, a single transmembrane region and tandem C2 domains in the cytoplasmic domain. In some cases, however, alternatively spliced variants (e.g. Syt VI∆TM) have been reported [22, 23] . Involvement of Syt family members in vesicular traffic, other than in synaptic vesicle exocytosis, was reported recently. For instance, Syt I is also involved in Ca# + -regulated exocytosis in some endocrine cells [16] [17] [18] , neurite outgrowth of chick dorsal root ganglion neurons [24] and axonal repair in squid giant axons and PC12 cells [25, 26] . Syt III or Syt VII is Abbreviations used : GST, glutathione S-transferase ; HRP, horseradish peroxidase ; NxIα, neurexin Iα ; PC, dipalmitoyl L-α-phosphatidylcholine ; PS, dioleoyl L-α-phosphatidylserine ; RACE, rapid amplification of cDNA ends ; RT, reverse transcriptase ; Syt, synaptotagmin.
1 To whom correspondence should be addressed (e-mail mnfukuda!brain.riken.go.jp). The nucleotide sequence reported here is deposited in the DDBJ, EMBL and GenBank Nucleotide Sequence Databases under accession number AB048947.
Because of these substitutions, the Syt XIII C2 domains did not show Ca# + -dependent phospholipid-binding activity, and Syt XIII is thus classified as a Ca# + -independent isoform. By contrast, the Syt XIII C-terminal domain is highly homologous with other Syt isoforms and can function as a common receptor for neurexin Iα in itro. Since Syt XIII is expressed in various tissues outside the brain, Syt XIII may be involved in constitutive vesicle transport.
Key words : C2 domain, oligomerization, phospholipid binding, vesicle docking, vesicle transport. involved in insulin secretion by pancreatic β-cells [27] [28] [29] . Syt VII regulates Ca# + -dependent lysosomal exocyotosis in fibroblasts [30] . These findings suggest that the Syt family regulates various types of vesicular traffic, although the exact subcellular localization of most of the isoforms remains largely unknown.
Herein, we report the cDNA sequence of a mouse orthologue of human KIAA1427 protein [31] . We characterized this protein as an atypical type of Syt, and designated it Syt XIII. Syt XIII also shows type-I membrane topology, but, unlike other Syt isoforms, it lacks an extracellular domain at its N-terminus. We also examined the biochemical properties of Syt XIII and the tissue distribution of Syt XIII mRNA.
MATERIALS AND METHODS

Materials
Ex Taq and recombinant Taq DNA polymerases were obtained from Takara Shuzo Co. (Shiga, Japan) and Toyobo Biochemicals (Tokyo, Japan), respectively. Polyclonal and monoclonal antibodies (M2) against FLAG peptide were obtained from Zymed Laboratories (San Francisco, CA, U.S.A.) and Sigma (St. Louis, MO, U.S.A.), respectively. Horseradish peroxidase (HRP)-conjugated anti-(T7 tag) antibody and anti-(T7 tag) antibodyconjugated agarose were from Novagen (Madison, WI, U.S.A.). Dipalmitoyl -α-phosphatidylcholine (PC) and dioleoyl -α-phosphatidylserine (PS) were from Sigma. All other chemicals were commercial products of reagent grade. Solutions were made up in deionized water prepared with an Elix10 Water Purification System and Milli-Q Biocel A10 System (Millipore Corp., Bedford, MA, U.S.A.).
Molecular cloning of mouse Syt XIII
cDNAs encoding the open reading frame of mouse Syt XIII were amplified from Marathon-Ready mouse adult brain cDNA by 5h-rapid amplification of cDNA ends (RACE ; Clontech Laboratories, Palo Alto, CA, U.S.A.) as described previously [32] . The first 5h-RACE reactions were carried out using an adapter primer 1 (5h-CCATCCTAATACGACTCACTATAG-GGC-3h) and the following primer designed on the basis of the mouse EST sequence database (accession number AI050367) ; 5h-CTACAGGTGCAGTTGGTGCCACAT-3h (C1 primer, antisense ; amino acid residues 420-426). The second 5h-RACE reactions were carried out using an internal adapter primer 2 (5h-ACTCACTATAGGGCTCGAGCGGC-3h) and the following primer designed on the basis of the mouse EST sequence ; 5h-AGCAAGTCATCCGGTAGCTC-3h (C2 primer, antisense ; amino acid residues 363-369). Both PCRs were carried out in the presence of Perfect Match PCR Enhancer (Stratagene, La Jolla, CA, U.S.A.) for 35 cycles, each consisting of denaturation at 94 mC for 1 min, annealing at 55 mC for 2 min and extension at 72 mC for 3 min. The first and second PCR products were purified from an agarose gel on a Micro-Spin column (Amersham Pharmacia Biotech, Little Chalfont, Bucks., U.K.) as described previously [33] , and they were inserted directly into the pGEM-T Easy vector (Promega, Madison, WI, U.S.A.). Both strands of the cDNA inserts were randomly sequenced with a Hitachi SQ-5500 DNA sequencer until a cDNA clone including the putative initiation methionine was obtained.
Expression constructs
Full-length Syt XIII cDNA including the open reading frame was constructed using appropriate restriction-enzyme sites on the pGEM-T Easy vector (named pGEM-T-Syt XIII). pEF-T7 (or -FLAG in place of -T7) -Syt XIII, -Syt XIII∆N and -N-Gly-Syt XIII were constructed by PCR using Met primer (5h-GCGGA-TCCATGGTGCTGTCGGTGCCT-3h ; amino acid residues 1-6) or ∆N primer (5h-GCGGATCCCGACACATGCACCC-CAAGAA-3h ; amino acid residues 31-37) and C1 primer as described previously [33] . Other expression constructs (pEF-T7-Syt I, -Syt VI∆TM, -FLAG-Syt VI∆TM and -Syt XI) were prepared as described previously [21, 22, 33] . Plasmid DNA was prepared using Wizard mini preps (Promega) or QIAGEN Maxi prep kits.
Preparation of glutathione S-transferase (GST) fusion proteins
The pGEX-4T-3 vector (Amersham Pharmacia Biotech), carrying fragments of the Syt XIII C2A or C2B domains, was essentially constructed by PCR [34] using pGEM-T-Syt XIII as a template. The following pairs of oligonucleotides with appropriate restriction-enzyme sites (underlined) and\or termination codons (bold letters) were used for amplification : C2A upper primer (sense), 5h-GCGGATCCGAGAAGGCTGCCA-GCTGGAA-3h and C2A lower primer (antisense), 5h-GCACTAGTCACTTTGCTGTGGTCTTCAGCT-3h ; and C2B upper primer (sense), 5h-GCGGATCCGCAAAGGAGCCAT-CTGCAGG-3h and SP6 primer. The resulting pGEX-Syt XIII-C2A and -C2B were confirmed by DNA sequencing and transformed into Escherichia coli JM109. GST fusion proteins were expressed and purified on glutathione-Sepharose (Amersham Pharmacia Biotech) by the standard method [35] . GST-Syt XIII-C2A and GST-Syt XIII-C2B encoded amino acids 151-282 and 281-426 of mouse Syt XIII, respectively. GST-Syt I-C2A was prepared as described previously [34] .
Subcellular fractionation
COS-7 cells transfected with pEF-Syt constructs (5i10& cells\ 10 cm dish, the day before transfection) were harvested 3 days after transfection and homogenized in 1 ml of 0.32 M sucrose\ 1 mM EDTA\0.1 mM PMSF\10 µM leupeptin\10 µM pepstatin A\1 mM β-mercaptoethanol\5 mM Tris\HCl, at pH 7.5, in a glass-Teflon Potter homogenizer with 10 strokes at 900-1000 rev.\min. The homogenate was centrifuged at 1000 g for 10 min at 4 mC. The supernatant (300 µl) was further centrifuged at 100 000 g for 1 h at 4 mC to precipitate membrane fractions. The membrane fractions were resuspended in 300 µl of 1 M NaCl or 0.1 M Na # CO $ , at pH 11, containing protease inhibitors. After incubation for 1 h at 4 mC, the membrane fractions were precipitated by centrifugation at 100 000 g for 1 h at 4 mC, and were dissolved in 300 µl of SDS sample buffer. Then, 10 µl each of supernatants and membrane fractions were subjected to SDS\PAGE (10 % gels) and analysed by immunoblotting as described previously [22, 33] .
Uptake of anti-FLAG antibody
Transfection of pEF-FLAG-Syts into PC12 cells [(0.8-1)i10& cells\35 mm dish, the day before transfection ; MatTek Corp., Ashland, MA, U.S.A.] was performed as described previously [22] . Before fixation (3 h), PC12 cells expressing pEF-FLAG-Syt XIII, pEF-FLAG-Syt VI∆TM or pEF-FLAG-Syt XI were incubated in medium containing anti-FLAG (M2) antibody (3 µg\ml). After being washed twice with PBS, the cells were fixed and the incorporated antibodies were visualized by antimouse Alexa 568 antibody (Molecular Probes, Eugene, OR, U.S.A.). Total FLAG-Syt proteins were stained separately with anti-FLAG (0.5 µg\ml) rabbit polyclonal antibody and antirabbit Alexa 488 antibody (Molecular Probes) as described previously [22, 36] . Immunoreactivity was analysed using a fluorescence microscope (TE300, Nikon, Tokyo, Japan) attached to a laser confocal scanner unit CSU 10 (Yokogawa Electric Corp., Tokyo, Japan) and a HiSCA CCD camera (C6790, Hamamatsu Photonics, Hamamatsu, Japan). Images were pseudo-coloured and superimposed using Adobe Photoshop version 4.0.
Neurexin Iα (NxIα) binding assay
cDNA encoding the cytoplasmic portion of the mouse NxIα was amplified by reverse transcriptase (RT)-PCR from mouse cerebellum cDNAs [34] using the following set of primers designed on the basis of previously reported rat sequences [37] : 5h-GCGGATCCATGTACAAGTACAGAAACCGG-3h (sense, amino acids 1452-1458) and 5h-GCGAATTCTCAGACATAA-TACTCCTTAT-3h (antisense, amino acids 1502-1507). Reactions were carried out in the presence of Perfect Match PCR Enhancer for 30 cycles, each consisting of denaturation at 94 mC for 1 min, annealing at 55 mC for 1 min and extension at 72 mC for 1 min. The PCR products were digested with BamHI\EcoRI (underlined above), and subcloned into the BamHI\EcoRI site of the pGEX-2T vector (Amersham Pharmacia Biotech). The resulting pGEX-2T-NxIα-C vector was confirmed by DNA sequencing. GST fusion proteins were prepared as described above. [53] . Note that the mouse Syt XIII has one hydrophobic region at the N-terminal domain, which may be responsible for the transmembrane domain.
After transfection (3 days), COS-7 cells (10 cm dish) expressing T7-Syt XIII∆N or T7-Syt VI∆TM were homogenized in 50 mM Hepes\KOH, pH 7.2\0.1 mM PMSF\10 µM leupeptin\10 µM pepstatin A, and the proteins were then solubilized with 1 % Triton X-100 at 4 mC for 1 h. After centrifugation at 17 360 g for 10 min at 4 mC, each lysate (400 µl) was incubated with glutathione-Sepharose beads coupled with 5 µg of GST-NxIα-C (or GST alone ; wet volume, 15 µl ; Amersham Pharmacia Biotech) for 1 h at 4 mC. After washing the beads with 1 ml of the incubation buffer five times, GST-NxIα-C protein-bound fractions were examined by SDS\PAGE (10 % gels) and immunoblotting with HRP-conjugated anti-(T7 tag) antibody as described previously [33] .
RT-PCR analysis
Mouse first-strand cDNAs prepared from various tissues and developmental stages were obtained from Clontech Laboratories (Mouse MTC Panel I). PCR reactions were carried out in the presence of Perfect Match PCR Enhancer (Stratagene) for 30 or 35 cycles, each consisting of denaturation at 94 mC for 1 min, annealing at 55 mC for 2 min and extension at 72 mC for 2 min. The C2B upper and C1 primers described above were used for amplification. The PCR products were analysed by 1 % agarose gel and ethidium bromide staining. The authenticity of the products was verified by subcloning into the pGEM-T Easy vector and DNA sequencing.
Sequence analyses
Multiple sequence alignment and depiction of the phylogenetic tree of the mouse Syt family were performed using the CLUSTALW program (http :\\watson.genes.nig.ac.jp\ homology\clustalw.shtml) and the appropriate default parameters (gapopen l 10, gapext l 0.05, gapdist l 8 and maxdiv l 40).
Miscellaneous procedures
Co-transfection of pEF-T7-Syts and pEF-FLAG-Syts into COS-7 cells (5i10& cells\10 cm dish, the day before transfection) was carried out using the LipofectAmine Plus reagent according to the manufacturer's instructions (Life Technologies, Rockville, MD, U.S.A.) [21, 22, 33] . Cells were harvested 3 days after transfection, and the proteins were solubilized with buffer containing 1 % Triton X-100, 250 mM NaCl, 50 mM Hepes\ KOH, pH 7.2, 0.1 mM PMSF, 10 µM leupeptin and 10 µM pepstatin A at 4 mC for 1 h. Immunoprecipitation of T7-Syts in the presence or absence of 500 µM Ca# + by anti-(T7 tag) antibodyconjugated agarose, SDS\PAGE (10 % gels) and immunoblotting analyses were also performed as described previously [33] . Preparation of liposomes consisting of PC and PS (1 : 1, w\w) and a phospholipid-binding assay were performed as described previously [38, 39] . The protein concentrations were determined with a Bio-Rad protein assay kit (Bio-Rad, Hercules, CA, U.S.A.) using BSA as a reference.
RESULTS
Characterization of KIAA1427 protein as Syt XIII
In a previous study, we searched for novel tandem C2 proteins from the mouse EST and genome sequence databases using the mouse Syts I-XII protein sequences [33] as bait [32] . We have identified and cloned five novel genes, including Doc2γ [32] , three related tandem C2 proteins without a transmembrane domain (M. Fukuda, unpublished work) and one putative Syt isoform ( Figure 1A) . The 1293 nucleotide sequence encoding a novel Syt isoform contains an open reading frame encoding 426 amino acids with a calculated molecular mass of 46 867 Da ( Figure 1A) . Homology search analysis indicated that this protein is an orthologue of human KIAA1427 protein (90 % identity at the amino acid level) [31] . Unexpectedly, however, the KIAA1427 protein is reportedly one of the single C2 domain-
Figure 2 Phylogenetic tree and the sequence alignment of the mouse Syt family
(A) Phylogenetic tree of mouse Syts I-XIII (Syt XII is also called srg1 [54] ). The phylogenetic tree is depicted as described in the Materials and methods section. Subfamilies of Syt isoforms are in shaded boxes (Syts I and II), white boxes (Syts III, V, VI and X) [33, 55] or dashed boxes (Syts IV and XI). (B) Sequence alignment of mouse Syt family C2 domains. Residues for which half of the sequences are conserved or similar are shown on black or shaded backgrounds, respectively. Asterisks indicate the five conserved aspartate or glutamate residues, which may be crucial for Ca 2 + binding by analogy with the Syt I C2A domain [49, 50] . F Indicates the position of the Lys residues responsible for Ins(1,3,4,5)P 4 binding, AP-2 [clathrin assembly (adapter) protein] binding and self-oligomerization of Syt I (the so-called C2B effector domain) [47, 51] . The dashed lines and solid line indicate the two C2 domains and the Nx-binding site [40] , respectively. Amino acid numbers are indicated to the right. . Membrane (M) and soluble (S) fractions were separated as described in the Materials and methods section. The membrane fraction was further resuspended in a buffer containing 1 M NaCl or 0.1 M Na 2 CO 3 , at pH 11, and incubated for 1 h at 4 mC. After centrifugation at 100 000 g for 1 h, the supernatants (Su) were recovered. Equal proportions (10 µl) of total (T), membrane, soluble and supernatant fractions treated with 1 M NaCl or 0.1 M Na 2 CO 3 , pH 11, were subjected to SDS/PAGE (10 % gels) and transferred to a PVDF membrane (Millipore), followed by immunoblotting with HRPconjugated anti-(T7 tag) antibody. Note that membrane association of Syt XIII is insensitive to both treatments, as is the case with Syt I. By contrast, deletion of the N-terminal hydrophobic region of Syt XIII (Syt XIII∆N) resulted in dissociation from the membrane with the above treatments, as was observed with Syt VI∆TM. Asterisks indicate the non-specific interaction of HRP-conjugated anti-(T7 tag) antibody. The positions of the molecular-mass markers (kDa) are shown on the right. The results shown are representative of three independent experiments.
containing proteins lacking a transmembrane domain [31] . Sequence alignment of the mouse orthologue of human KIAA1427 protein with mouse Syt isoforms shows clearly that it contains the C2A domain, C2B domain (broken lines in Figure  2B ) and HWX "$ WHXL motif at the C-terminus (solid line in Figure 2B ), which is a consensus sequence for Nx binding [40] . In addition, the hydrophobic profile of the mouse orthologue of human KIAA1427 protein shows the hydrophobic region to be present at the N-terminus ( Figure 1B) , although its hydrophobicity is weaker than that of Syt I (results not shown). Therefore, we tentatively identified KIAA1427 as the 13th isoform of Syt (Syt XIII).
To examine whether the N-terminal hydrophobic region is indeed essential for membrane association, the mouse Syt XIII protein was expressed in COS-7 cells and its membrane association was evaluated by subcellular fractionation (see the Materials and methods section for details). As shown in Figure  3 (top and third panels), the Syt XIII proteins were recovered only from the membrane fraction, and this association was resistant to treatments with 1 M NaCl and 0.1 M Na # CO $ , at pH 11, as were Syt I proteins. Under these conditions, most peripheral membrane proteins were expected to be released from membranes. By contrast, membrane association of Syt VI∆TM, a major alternatively spliced variant lacking a transmembrane domain [22] , was highly sensitive to treatments with both 1 M NaCl and 0.1 M Na # CO $ at pH 11 ( Figure 3 , second panel from the top). When the hydrophobic region of Syt XIII (amino acid residues 1-30) was deleted, Syt XIII∆N proteins were also recovered from the membrane fraction, but were released from the membrane by the above treatments (Figure 3, bottom panel) . These results indicate that the Syt XIII protein has at least two independent mechanisms for membrane association ; the Nterminal hydrophobic region responsible for 1 M NaCl-and 0.1 M Na # CO $ -resistant membrane associations, and the Cterminal domain containing two C2 domains responsible for 1 M NaCl-and 0.1 M Na # CO $ -sensitive membrane associations (see also Figure 6 , below).
Figure 4 Characterization of Syt XIII as a type-I membrane protein
FLAG-Syt VI∆TM (A-C), -Syt XI (D-F) and -Syt XIII (G-I) were expressed in PC12 cells. PC12 cells were cultured in medium containing anti-FLAG (M2) (in B, E and H).
Since Syt XIII has a putative palmitoylation site just after the hydrophobic region, which may also be responsible for membrane association [41, 42] , we further examined whether Syt XIII is an integral membrane protein (i.e. type-I membrane protein). To address this possibility, we performed anti-FLAG antibodyuptake experiments (Figure 4) . When PC12 cells expressing FLAG-Syt XI, an integral membrane protein mainly associated with Golgi ( Figure 4D , green), were cultured in the presence of anti-FLAG (M2) antibody for 3 h, the anti-FLAG antibodies were incorporated into the cells via endocytosis by recognizing the extracellular N-terminal domain of FLAG-Syt XI ( Figure  4E , red dots ; Figure 4F , superimpositions of D and E). The incorporation of antibody completely depended on the expression of FLAG-Syt XI proteins, because untransfected cells took up virtually no antibodies (results not shown). When FLAG-Syt
Figure 5 Self-oligomerization property of Syt XIII
Top panel : total homogenates of COS-7 cells expressing FLAG-Syt VII, -Syt XIII or -Syt XIII∆N were subjected to SDS/PAGE (10 %) and analysed by immunoblotting with anti-FLAG rabbit antibody (5 µg/ml). Middle panel : pEF-T7-Syt VII, XIII or XIII∆N and pEF-FLAG-Syt VII, XIII or XIII∆N were co-transfected into COS-7 cells. Expressed proteins were solubilized with 1 % Triton X-100 and immunoprecipitated by anti-(T7 tag) antibody-conjugated agarose as described previously [22, 33] . Co-immunoprecipitated FLAG-Syts (IPP) were first detected by anti-FLAG rabbit antibody (5 µg/ml). XIII proteins were expressed in PC12 cells, they were localized mainly in the peri-nuclear region (probably Golgi), but there were also several dots in the cytosol, apparently indicating transport from the Golgi to the plasma membrane ( Figure 4G , green). The FLAG-Syt XIII-expressing cells also took up antibodies which appeared as numerous dots ( Figure 4H , red dots ; Figure 4I , superimpositions of G and H). By contrast, FLAG-Syt VI∆TM-expressing cells could not take up antibodies ( Figure  4B, red) , although FLAG-Syt VI∆TM protein itself showed enrichment around the plasma membrane (Figure 4A , green ; Figure 4C , superimpositions of A and B) [22] . In some cases, a few red dots were associated with the plasma membrane in FLAG-Syt VI∆TM-expressing cells ( Figure 4C, arrowhead) , which may represent a non-specific interaction of antibody with the plasma membrane. In addition, T7-N-Gly-Syt XIII, which carries an artificial N-glycosylation site at the N-terminus [21] , could not be N-glycosylated, probably due to the proximity of the recognition sequence to the transmembrane domain (results not shown). Therefore, we concluded that Syt XIII is indeed a type-I membrane protein lacking an extracellular N-terminal domain, although it lacks a signal peptide sequence.
Self-oligomerization properties of Syt XIII
Recently, we and others found several Syt isoforms from Ca# + -dependent (via the C2 domains) and -independent (via the Nterminal domain) homo-or hetero-oligomers [21, 33, [43] [44] [45] [46] [47] [48] . At least in Syt I, self-oligomerization activity is believed to be essential for efficient Ca# + -dependent neurotransmitter release, based on analysis of Drosophila syt I mutants (reviewed in [10] ). To examine whether Syt XIII also shows this oligomerization property, we performed T7-and FLAG-Syts co-expression assays
Figure 6 Phospholipid-binding properties of Syt XIII C2 domains
Liposomes and GST fusion proteins were incubated in 50 mM Hepes/KOH, at pH 7.2, in the presence of 2 mM EGTA (k) or 1 mM Ca 2 + for 15 min at room temperature. After centrifugation at 12 000 g for 10 min, the supernatants (S, non-binding fraction) and pellets (P, phospholipid-binding fraction) were separated as described previously [38, 39] . Equal proportions of the supernatants and pellets were subjected to SDS/PAGE (10 % gels) and then stained with Coomassie Brilliant Blue R-250. Note that the C2A domain of Syt XIII did not bind liposomes, whereas the C2B domain of Syt XIII did bind liposomes regardless of whether Ca 2 + was present. By contrast, the C2A domain of Syt I bound liposomes only in a Ca 2 + -dependent manner. The bottom panel indicates the negative control, GST. The results shown are representative of three independent experiments. [21, 33, 43] . As shown in Figure 5 , both Syt XIII and Syt XIII∆N showed only weak Ca# + -independent self-oligomerization activity, whereas there was no Ca# + -dependent oligomerization activity. Consistent with this, Syt XIII essentially lacks the C2B effector domain responsible for Ca# + -dependent oligomerization, as demonstrated in Syt I [47] (Figure 2B, F) . By contrast, Syt VII showed robust Ca# + -dependent oligomerization activity [21, 43] .
Phospholipid-binding properties of Syt XIII C2 domains
The C2 domains of Syt family members were originally identified in Ca# + -dependent protein kinase C, and some have been shown to possess Ca# + -dependent phospholipid-binding activity (reviewed in [5] ). In Syt I, the Ca# + \phospholipid-binding site of the C2A domain has been shown to be important for secretory vesicle exocytosis [13, [15] [16] [17] . Crystallographic and mutational analyses of the Syt I C2A domain indicated that five aspartate (or glutamate) residues are essential for Ca# + binding [49, 50] (see Figure 2B , *). Interestingly, Syt XIII lacks such aspartate or glutamate residues in both C2A and C2B domains, suggesting that Syt XIII should be classified as a Ca# + -independent Syt isoform. To address this issue, a phospholipid (PS\PC liposomes)-binding assay was performed using GST fusion proteins (Figure 6 ). GST-Syt XIII-C2A did not bind PS\PC liposomes regardless of whether Ca# + was present [only recovered in the supernatant (S) fraction ; 
NxIα binding to Syt XIII
Although Syt XIII lacks the effector domain for Ca# + in the C2A domain ( Figure 2B , *), as well as that for self-oligomerization in the C2B domain ( Figure 2B, F) , the short C-terminus of Syt XIII is highly homologous to that of other isoforms ( Figure 2B , underlined sequence). This domain is essential for NxIα binding in itro [40] , and is suggested to be involved in the docking of vesicles to plasma membranes. As expected, Syt XIII bound GST-NxIα-C, but not GST alone, regardless of whether Ca# + was present (Figure 7, lanes 3 and 4) .
Tissue distribution of Syt XIII
To examine the tissue distribution of mouse Syt XIII, RT-PCR was performed with specific primers (Figure 8 ). Syt XIII mRNA was found in all tissues tested, except for liver, and its expression levels were highest in the brain, lung and testis. In addition, expression of Syt XIII mRNA seemed to peak on embryonic day 7 and thereafter gradually decreased to the adult level.
DISCUSSION
In this study, we isolated and characterized KIAA1427 protein as a novel Syt isoform that has a single transmembrane domain, two C2 domains and a short C-terminus, and this protein was thus designated Syt XIII. Syt XIII is distinguishable from other Syt isoforms in that it lacks an extracellular N-terminal domain (summarized in Figure 9 ) and is classified as belonging to a new Syt subfamily, as demonstrated by phylogenetic analysis ( Figure  2A ). Sequence alignment of the mouse Syt family indicates that Syt XIII lacks aspartate (or glutamate) residues responsible for Ca# + binding in both C2 domains [49, 50] (G189, T245 and S253 in the C2A domain ; S319, G380, G382 and C388 in the C2B domain ; Figure 2B , asterisks). Because of this substitution, the Syt XIII C2A domain has no phospholipid-binding activity, whereas the Syt XIII C2B domain binds phospholipids regardless of whether Ca# + is present (Figure 6 ). In addition, although the putative C2B effector domain is highly conserved among Syts I-XII (Lys clusters, F in Figure 2B ), the corresponding region of Syt XIII is not always occupied by positively charged amino acids (Lys or Arg) ( Figure 2B, F) . Therefore, the Syt XIII C2B domain is unlikely to bind inositol polyphosphates or the C2B domain itself with high affinity [47, 51] . Indeed, Syt XIII did not show Ca# + -dependent self-oligomerization activity ( Figure  5 ). In contrast with the different biochemical properties of Syt family C2 domains, the short C-terminal domain (HWX "$ WHXL motif ) has been highly conserved during evolution as well as among Syt family members, and Syt XIII also bound NxIα in itro ( Figure 7 ). In addition, we recently showed that the conserved C-terminus of the Syt family is essential for plasmamembrane association [22, 52] and that the Syt I C-terminus is indeed involved in synaptic vesicle docking to presynaptic plasma membranes in the squid giant synapse [52] . Therefore, it is likely that Syt XIII may be involved in the docking of vesicles to plasma membranes [40] rather than Ca# + -regulated exocytosis, because the C2 domains of Syt XIII did not show Ca# + -dependent properties. When Syt XIII is expressed in PC12 cells, Syt XIII proteins are apparently transported from the Golgi-like perinuclear compartment to the cell periphery (plasma membrane) constitutively via vesicle transport (Figure 4 ). Taking these observations together, and given that Syt XIII is expressed in various tissues outside the brain (Figure 8 ), we speculate that Syt XIII is involved in constitutive vesicle traffic, especially at docking step of transport vesicles to plasma membrane. Further work is necessary to determine whether Syt XIII is involved in transport vesicle docking to the plasma membrane. In summary, we identified an atypical isoform of Syt, and designated it Syt XIII. Based on the biochemical properties of Syt XIII C2 domains and the C-terminus, we suggest that Syt XIII may be involved in the docking of vesicles to plasma membranes via a constitutive pathway.
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